What is the Buying Price of Onesource Specialty Pharma Share?

The Buying Price of Onesource Specialty Pharma share is 1791.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Onesource Specialty Pharma Share at Choice?

To buy Onesource Specialty Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Onesource Specialty Pharma, choose your preferred order type, and place the trade.

What is the PE ratio of Onesource Specialty Pharma Shares?

The Price-to-earnings (P/E) ratio of Onesource Specialty Pharma shares is 0. You can compare it with the sector average for relative valuation.

What is the PB ratio of Onesource Specialty Pharma Shares?

The Price to Book (P/B) ratio Onesource Specialty Pharma shares is 3.54. Useful to assess the stock's value relative to its book value.

Is Onesource Specialty Pharma Overvalued?

To assess Onesource Specialty Pharma’s valuation compare Sector P/E, P/B which are 71.44 & 3.49 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Onesource Specialty Pharma?

The Market Cap of Onesource Specialty Pharma is 20529.80 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Onesource Specialty Pharma Share Price?

The 52 week high and low prices of Onesource Specialty Pharma share price is 2248 & 1057. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Onesource Specialty Pharma belong to?

Onesource Specialty Pharma belongs to the Healthcare sector.

Onesource Specialty Pharma Share price

ONESOURCE

Healthcare Large Cap

1791.1

14.50 (-0.80%)

NSE

BSE

Last updated on 27 May, 2026 | 15:31 IST

BUYSELL

Today's High

1821.90

Today's Low

1760.40

52 Week Low

1057.00

52 Week High

2248.00

Free Demat with Zero AMC*

Onesource Specialty Pharma Chart

ChartIQ

TradingView

Onesource Specialty Pharma Share Key Metrics

Volume

1.55 L

Market Cap

20529.80 CR

LTQ@LTP

50@1791.10

ATP

1786.4

Var Margin

21.27 %

Circuit Range

1444.5-2166.7

Delivery %

50.65 %

Value

27.69 CR

ASM/GSM

No

Market Lot

1

Summary

27 May, 2026 | 15:31 को, Onesource Specialty Pharma का शेयर प्राइस आज ₹1791.1 पर है, जो दिन के लिए 14.50% की -0.80 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1760.40 और ₹1821.90 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1057.00 से ₹2248.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Onesource Specialty Pharma ने 155030 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹114621201 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹178640 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 50,179110 रही। यह स्टॉक ₹1444.5-2166.7 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹27.69 CR है। दिन के लिए डिलीवरी परसेंटेज 50.65% रही। इसके अतिरिक्त, Onesource Specialty Pharma वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Onesource Specialty Pharma Fundamentals

P/E Ratio

0

P/B Ratio

3.54

Div. Yield

0

Sector P/E

71.44

Sector P/B

3.49

Sec. Div. Yield

0.55

Onesource Specialty Pharma Resistance and Support

Pivot 1800.83

Resistance

First Resistance

1828.66

Second Resistance

1851.73

Third Resistance

1879.56

Support

First Support

1777.76

Second Support

1749.93

Third Support

1726.86

Onesource Specialty Pharma Shareholding Pattern

2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

30.48%

Mutual Fund

10.13%

Insurance

3.35%

Foreign Institutional Investors

17.5%

Domestic Institutional Investors

7.13%

Retail

31.41%

Others

0%

Total Promoters

MAR '26

30.48%

Onesource Specialty Pharma Corporate Actions

Date	Agenda
2026-05-13	Audited Results
2026-01-23	Quarterly Results

Onesource Specialty Pharma News

Onesource Specialty Pharma Limited

OneSource Specialty Pharma Ltd. released its Q4 and full year FY26 earnings call transcript. The company reported Q4 revenue of Rs.4,282 million and adjusted PAT of Rs.390 million, emphasizing strong sequential growth and the reaffirmation of its US$400 million FY28 organic revenue target.

May 19 2026 18:53:41

Onesource Specialty Pharma gets government nod for Unit II expansion project

Onesource Specialty Pharma has received in-principle approval from the Government of Karnataka for the expansion of its Unit II facility. This approval falls under the Karnataka Industrial Policy 2025–30 and includes incentives and concessions, aiming to enhance the company's manufacturing capacities to serve global partners.

May 16 2026 15:10:31

Onesource Specialty Pharma Limited

Onesource Specialty Pharma Ltd received in-principle approval from the Government of Karnataka for its Unit II expansion project. This approval includes incentives and concessions under the Karnataka Industrial Policy 2025-30, aimed at enhancing manufacturing capacities for global partners.

May 16 2026 13:15:28

Onesource Specialty Pharma Ltd - 544292 - General-Update

Onesource Specialty Pharma secured in-principle approval from the Karnataka Government for its Unit II expansion project. This approval includes incentives and concessions under the KIP 2025-30, enhancing manufacturing capacities for global partners.

May 16 2026 13:13:28

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Onesource Specialty Pharma announced strong Q4 FY26 results with revenue growing 47% QoQ to Rs.4,282 million and EBITDA expanding over 5x. The company also reaffirmed its FY28 guidance.

May 13 2026 13:46:44

Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated May 13, 2026 For Approval Of The Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026

Onesource Specialty Pharma board approved FY26 financial results, reporting a cons. net loss of ₹738.03 mn, significantly widening from ₹179.71 mn loss in FY25. Also appointed B S R & Co LLP as new statutory auditors for 5 years, replacing Deloitte Haskins & Sells.

May 13 2026 13:04:06

Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015

Onesource Specialty Pharma's Board of Directors is scheduled to meet on May 13, 2026. The agenda includes considering and approving the audited financial results for the quarter and year ended March 31, 2026.

May 07 2026 18:48:09

Onesource Specialty Pharma Limited

Onesource Specialty Pharma Ltd. partner Orbicular received Health Canada approval for a generic version of Ozempic® (semaglutide injection). This enables commercialization for the first two generic entrants in Canada's significant semaglutide market, with OneSource supporting manufacturing from its US FDA-approved facility in Bengaluru.

May 04 2026 08:28:53

Onesource Specialty Pharma Limited

Onesource Specialty Pharma Ltd. partner Orbicular received Health Canada approval for a generic version of Ozempic® (semaglutide injection). This enables commercialization for the first two generic entrants in Canada's significant semaglutide market, with OneSource supporting manufacturing from its US FDA-approved facility in Bengaluru.

May 04 2026 08:28:53

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

OneSource Specialty Pharma's partner, Orbicular, received Health Canada approval for a generic version of Ozempic (semaglutide injection). This enables commercialization in Canada's significant market, with OneSource providing manufacturing from its US FDA-approved facility, strengthening its CDMO presence.

May 04 2026 08:27:02

Name	Position
A Trisha	Company Secretary & Compliance Officer
Arun Kumar	Chairman

Onesource Specialty Pharma Similar Stocks

Acutaas Chemicals Ltd.

3000.60

-34.20 (1.13%)

Piramal Pharma Ltd.

174.24

-4.62 (2.58%)

Neuland Laboratories Ltd.

16772.00

-299.00 (1.75%)

Pfizer Ltd.

4622.60

-19.20 (0.41%)

Natco Pharma Ltd.

1175.80

-10.20 (0.86%)

Astrazeneca Pharma India Ltd.

8648.00

-314.50 (3.51%)

Granules India Ltd.

782.60

26.10 (3.45%)

Eris Lifesciences Ltd.

1350.80

-10.60 (0.78%)

Cohance Lifesciences Ltd.

428.75

-6.15 (1.41%)

Jubilant Pharmova Ltd.

991.75

6.55 (0.66%)

Onesource Specialty Pharma FAQs

Onesource Specialty Pharma शेयर का खरीद मूल्य 1791.1 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Onesource Specialty Pharma शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Onesource Specialty Pharma शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Onesource Specialty Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.54 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Onesource Specialty Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.49 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Onesource Specialty Pharma का मार्केट कैप 20529.80 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Onesource Specialty Pharma शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2248.00 और 1057.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।